Taken together, PMEPA1 isoforms might function as biomarkers for monitoring disease progression and aggressive clinical outcome via representing surrogate for status of androgen and TGF-β signaling in prostate cancer. This evidence concerns the gene TGFB1 and prostate carcinoma.